Regeneron weight-loss drug halves muscle loss when combined with semaglutide
An experimental weight-loss drug from Regeneron reduced muscle mass loss by 50% when used in combination with Novo Nordisk's semaglutide, compared to semaglutide alone, according to trial results presented at a medical meeting.
